Suppressing Neuroinflammation: T-REG Cell Therapy of ALS
Time: 5:00 pm
day: Day One
Details:
- Analyzing T-regs dysfunctional in neurodegenerative diseases to aid future therapeutic development
- Understanding how ex vivo expansion restores T-Reg suppressive function to highlight neuroprotective factors that may arise from targeting neuroinflammation
- Using clinical trial data to highlight how autologous T-reg infusions slow disease progression to thus suggest a potential avenue towards curing neurodegenerative diseases
